Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01373827Completed

Protocol To Evaluate Patient Measurements After Ultrasonic Treatment

Role: lead

NCT01313000Completed

Study To Evaluate Upper Arm Autologous Fat Transfer

Role: lead

NCT00731354Phase 4Completed

VASER-Assisted Lipoplasty Compared With Suction-Assisted Lipoplasty

Role: lead

NCT01260298Completed

Protocol To Evaluate Patient Measurements After Ultrasonic Treatment

Role: lead

NCT00735293Phase 4Completed

VASER Treatment of Axillary Hyperhidrosis/Bromidrosis

Role: collaborator

All 5 trials loaded